samedan logo
 
 
spacer
home > ict > autumn 2008 > clinical trials benefit from advanced lims
PUBLICATIONS
International Clinical Trials

Clinical Trials Benefit From Advanced LIMS

Laboratory information management systems (LIMS) are widely used to automate laboratory processing and to assist with regulatory compliance. Organisations that installed LIMS many years ago are now turning their attention to new-generation products that take advantage of the latest capabilities and enhanced flexibility.

Clinical trial companies must remain competitive and able to adapt quickly to the demands of a fast-paced market and their clients. The advanced features and configurability of newgeneration LIMS products offer clinical trials businesses more flexibility, and opportunities to enhance their service. However, introducing a new laboratory software system is not without its challenges, and requires careful planning and good support from the vendor. This article outlines the preparations for, and delivery of, a new-generation LIMS product into a busy Phase I clinical trials laboratory.

WHY INTRODUCE A NEW-GENERATION LIMS?

Many companies have benefited from laboratory automation since adopting LIMS in the 1980s and 90s. These systems have served well, but as time goes by, it often proves increasingly difficult to enhance the software to...

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Robin Longdin is responsible for overseeing and managing the activities of LCG Bioscience’s clinical and biomarker laboratories. Robin has a BSc in Microbiology from the University of Leicester, a year of which was spent at the University of the Algarve. He joined LCG Bioscience’s clinical laboratories in 2001, working in the haematology and biochemistry laboratory, before taking on responsibility for data management through the laboratory and out to external customers. In his previous role as Biomarker Project Scientist, he specialised in developing and performing analytical methods to support the use of biomarkers in LCG Bioscience’s clinical studies. He is currently taking an MSc in Science Communication at the University of the West of England.

Nick Townsend is Director of Life Sciences for LabWare Europe and has worked in the LIMS industry for over 25 years. After graduating in Biochemistry, he first became interested in the application of IT in the laboratory while working at in a major pharmaceutical company. Over the years, Nick has accumulated wide-ranging experience of developing, implementing and selling LIMS on an international basis.

spacer
Robin Longdin
spacer
spacer
spacer
Nick Townsend
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Stevanato Group signs an agreement with Nelson Labs to provide best-in-class Extractables and Leachables testing services at its US Technology Excellence Center

Piombino Dese, Padua Italy and Salt Lake City, USA September 2, 2020: Italian-based Stevanato Group, a leading producer of glass primary packaging and provider of integrated services for combination products, and Nelson Laboratories, LLC, a global provider of lab testing and expert advisory services signed today a partnership agreement that will provide Extractables and Leachables testing at SG US Technology Excellence Center in Boston, MA.
More info >>

White Papers

pAVEway™ expression system for the efficient expression of therapeutic proteins

Fujifilm Diosynth Biotechnologies

One of the major bottlenecks in the production of biopharmaceuticals is the efficient expression of therapeutic proteins in microbial or mammalian cells. The Escherichia coli pAVEway™ expression system described here has been developed to ensure high product titres and efficient scale up to GMP manufacture, whilst minimising many common issues seen in other expression systems, such as ‘leaky’ expression (expression of recombinant protein in the absence of inducer).
More info >>

 
Industry Events

Clinical Operations in Oncology Trials West Coast

17-18 November 2020, Hilton San Francisco Airport Bayfront

Clinical Operations in Oncology Trials West Coast will be returning this April for another 2 day event full of thought-provoking presentations, discussions and roundtables. This years' conference highlights include the high-level, interactive immuno-oncology discussion panel where specialists from Shasta Bio Ventures, Abbvie and BeiGene shared their top tips on how to run successful and impactful immuno-oncology studies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement